WESTMINSTER,
Calif., July 10, 2018 (GLOBE NEWSWIRE) -- BioLargo, Inc. (OTCQB:BLGO),
an innovator of sustainable science and technology and full-service
environmental engineering company, announced that on July 2, 2018,
holders of notes in the aggregate principal amount of $280,000, maturing
July 17, 2018, had offered to convert the outstanding principal and
interest into BioLargo common stock at $0.25 per share, and the company
had accepted the offer and issued the shares. In the same Form 8-K, the
company also reported holders of notes maturing September 18, 2018 and
October 16, 2018 had converted $25,000 and $98,737, respectively.
In
connection with these conversions, the company issued 494,949 shares of
its common stock that had been registered on Form S-1, and an
additional 1,153,600 shares that were issued without restriction
pursuant to Rule 144 at the request of the investors. BioLargo president
Dennis P. Calvert commented, “We are pleased that our investors are
able to take profits along our journey. Management’s belief in the
fundamentals of our business and expanding commercial prospects have
never been stronger.”
With these recent conversions, BioLargo
has reduced the debt obligations on its balance sheet by over $5.8
million in the last 90 days.
The Company intends to file its
results of operations for the second quarter on or before the SEC filing
deadline of August 14, 2018.
About BioLargo, Inc.
BioLargo, Inc. is an innovative technology incubator and environmental engineering company driven by a mission to “make life better”
by delivering robust, sustainable solutions for a broad range of
industries and applications, with a focus on clean water, clean air, and
advanced wound care. We incubate disruptive technologies by providing
the capital, support, and expertise to expedite them from “cradle” to
“maturity” (www.biolargo.com).
Our engineering division features experienced professional engineers
dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com),
which eliminates the odor-causing compounds and VOCs rather than
masking them, and is now winning over leading companies in the solid
waste handling and wastewater industries and other industries that
contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca)
develops the Advanced Oxidation System “AOS”, a disruptive industrial
water treatment technology designed to eliminate waterborne pathogens
and recalcitrant contaminants with better energy-efficiency and lower
operational costs than incumbent technologies. Our subsidiary Clyra
Medical (www.clyramedical.com)
features effective and gentle solutions for chronic infected wounds to
promote infection control and regenerative tissue therapy.
BioLargo
proudly and regularly publishes information about its employees,
products and activities through social media, including:
• Blogs at http://biolargo.blogspot.com/, http://biolargowater.blogspot.ca/, and http://biolargoengineering.blogspot.com/
• Facebook pages at:
You can follow our twitter feeds here:
• @BioLargo
• @BioLargoWater
• @OdorNoMore
• @CupriDyneClean
Company Contact
Dennis Calvert
President and CEO
BioLargo, Inc.
949-643-9540 x2
BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.
No comments:
Post a Comment